Travere Therapeutics, Inc. (TVTX)
27.23
-0.06
(-0.22%)
USD |
NASDAQ |
Mar 06, 16:00
27.70
+0.47
(+1.73%)
After-Hours: 20:00
Travere Therapeutics Cash from Investing (Quarterly) : -104.84M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 74.88M |
| ICU Medical, Inc. | -18.39M |
| Tandem Diabetes Care, Inc. | -14.98M |
| iRhythm Holdings, Inc. | -48.80M |
| Eli Lilly & Co. | -2.802B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 60.68M |
| Cash from Financing (Quarterly) | 26.68M |
| Free Cash Flow | -20.37M |
| Free Cash Flow Per Share (Quarterly) | 0.4631 |
| Free Cash Flow to Equity (Quarterly) | 42.83M |
| Free Cash Flow to Firm (Quarterly) | 44.21M |
| Free Cash Flow Yield | -0.81% |